Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma

SIMPLE SUMMARY: The primary treatment of malignant melanoma is a classical regimen of surgery combined with chemotherapy, targeted drugs, and immunotherapy. The purpose of this study was to explore the immune response mechanism of RNA binding protein RBM38 in the development of melanoma with the scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinfang, Xu, Jun, Luo, Binlin, Tang, Jian, Hou, Zuoqiong, Zhu, Zhechen, Zhu, Lingjun, Yao, Gang, Li, Chujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946480/
https://www.ncbi.nlm.nih.gov/pubmed/35326741
http://dx.doi.org/10.3390/cancers14061590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946480/
https://www.ncbi.nlm.nih.gov/pubmed/35326741
http://dx.doi.org/10.3390/cancers14061590

Ejemplares similares